Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate three dose levels of a combination of pyronaridine
and artesunate for the treatment of uncomplicated falciparum malaria in children.
Phase:
Phase 2
Details
Lead Sponsor:
Medicines for Malaria Venture
Collaborators:
Institute of Tropical Medicine, University of Tuebingen Shin Poong Pharmaceuticals